Ceres Nanosciences, Inc.

📍 MANASSAS, United States🗓 Founded 2008👥 40 employees💰 Last funded Jan 2018
Biotechnology Research🌐 ceresnano.com
Website LinkedIn
Ceres Nanosciences Inc. ("Ceres"​) is a privately held life sciences company engaged in the research, development, and commercialization of innovative sample preparation products, based on its proprietary Nanotrap® technology. The Nanotrap® technology, coupled with existing research and clinical diagnostic platforms, improves the sensitivity and accuracy of a wide array of critical diagnostic processes. Early detection of biomarkers, in particular those of low abundance, is key to the diagnosis and treatment of diseases such as cancer, cardiac, and infectious diseases, resulting in improved patient benefit and reduced health care costs. Ceres currently sells the Nanotrap® technology for use in a broad range of research and diagnostic applications.
3
Total investors
0
Early stage
0
Mid stage
2
Late stage
2008
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2015–2018 · investors recorded per year
2015120182
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Ceres Nanosciences, Inc.?
Ceres Nanosciences, Inc. has 3 investors on record on gritt.io and 2 late-stage investors.
When did Ceres Nanosciences, Inc. last raise funding?
The most recent investment in Ceres Nanosciences, Inc. recorded on gritt.io was in January 2018.
When was Ceres Nanosciences, Inc. founded?
Ceres Nanosciences, Inc. was founded in 2008.
What industry is Ceres Nanosciences, Inc. in?
Ceres Nanosciences, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Ceres Nanosciences, Inc. based?
Ceres Nanosciences, Inc. is headquartered in MANASSAS, United States.